OGEN vs V · rev $37.7K vs P/E 33, rev $40.00B
Oragenics Inc (OGEN) versus Visa Inc. Class A (V) — a side-by-side from cached financials, not a winner call.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
Visa Inc. Class A (V) is a credit services company listed on US. It is led by Ryan McInerney.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
Latest reported V revenue for 2025-09-30 was $40.00B. Net income was $20.06B. V currently screens at market cap $659.78B and trailing P/E 33.5.
OGEN currently screens at market cap $2.7M. V currently screens at market cap $659.78B and trailing P/E 33.5.
Not investment advice. Open the OGEN and V stock pages for the full models.
Not investment advice.